Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PASCAL Trabeculoplasty

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2008 by Asociación para Evitar la Ceguera en México.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:
NCT00804323
First received: December 5, 2008
Last updated: December 6, 2008
Last verified: December 2008

December 5, 2008
December 6, 2008
December 2007
December 2008   (final data collection date for primary outcome measure)
Intraocular Pressure [ Time Frame: During follow-up ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00804323 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
PASCAL Trabeculoplasty
Semi-Automated Patterned Laser Trabeculoplasty

Argon laser trabeculoplasty (ALT) with 100 ms pulses is an effective therapy for lowering intraocular pressure (IOP). Similar reductions in IOP have been achieved using ns (SLT) and microsecond (MLT) pulses, which produce less thermal damage to trabecular meshwork (TM). Lack of clinically visible changes may make the accurate alignment of subsequent pulses difficult. We describe a novel technique - Patterned Laser Trabeculoplasty (PLT) using the PASCAL Photocoagulator system, and its preliminary evaluation in patients with open angle glaucoma.

Not Provided
Interventional
Phase 4
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Open-Angle Glaucoma
Procedure: Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)
Pattern Scan Laser trabeculoplasty
Experimental: Group 1
Patients with open-angle glaucoma
Intervention: Procedure: Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
24
December 2009
December 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18-year-old patients
  • Uncontrolled Open angle (Shaffer IV)
  • No previous surgical trabeculoplasty or glaucoma surgery

Exclusion Criteria:

  • Patients not willing to participate
  • Angle-closure glaucoma
  • No clear optical media
Both
18 Years to 90 Years
No
Contact: Felix Gil Carrasco, MD 525510841400 ext 1163 glaucoma_apec@hotmail.com
Mexico
 
NCT00804323
APEC-041
Yes
Asociación para Evitar la Ceguera en Mexico, APEC
Asociación para Evitar la Ceguera en México
Not Provided
Principal Investigator: Felix Gil Carrasco, MD APEC
Asociación para Evitar la Ceguera en México
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP